×
About 7,605 results

ALLMedicine™ Community-acquired Pneumonia Center

Research & Reviews  2,242 results

Role of Chest Computed Tomography in Patients Hospitalized with Community-Acquired Comp...
https://doi.org/10.1016/j.amjms.2021.07.018
The American Journal of the Medical Sciences; Park JE, Cha SI et. al.

Dec 2nd, 2021 - Data regarding predictors of the outcome in patients with community-acquired complicated parapneumonic effusion (CPPE) or empyema are insufficient. The aim of the present study was to investigate the prognostic factors in these patients. Patients ...

A Prediction Model for Pediatric Radiographic Pneumonia.
https://doi.org/10.1542/peds.2021-051405
Pediatrics Ramgopal S, Ambroggio L et. al.

Dec 1st, 2021 - Chest radiographs (CXRs) are frequently used in the diagnosis of community-acquired pneumonia (CAP). We sought to construct a predictive model for radiographic CAP based on clinical features to decrease CXR use. We performed a single-center prospe...

Antimicrobial prescribing and outcomes of community-acquired pneumonia in Australian ho...
https://doi.org/10.1177/03000605211058366
The Journal of International Medical Research; Robert L, Mark V et. al.

Nov 27th, 2021 - We aimed to assess prescribing practices, compliance with guidelines, and outcomes for patients who were admitted to the authors' institution with community-acquired pneumonia (CAP). We performed a single-center retrospective cross-sectional study...

A Retrospective, Real-world Study of ELP Used in the Expectorant Treatment of Community-acquired Pneumonia
https://clinicaltrials.gov/ct2/show/NCT05002192

Nov 25th, 2021 - Through a series of retrospective analysis, it is hoped that an objective evaluation of the effect and safety of Eucalyptol, Limonene and Pinene Enteric Soft Capsules in the treatment of community-acquired pneumonia can be made.

Oral Nemonoxacin in Treating Elderly Patients With CAP
https://clinicaltrials.gov/ct2/show/NCT05133752

Nov 24th, 2021 - This study was to evaluate the safety and efficacy of oral nemonoxacin in treating elderly patients (aged ≥ 65 years) with community-acquired pneumonia (CAP).

see more →

Guidelines  8 results

Appropriate Use of Short-Course Antibiotics in Common Infections: Best Practice Advice ...
https://doi.org/10.7326/M20-7355
Annals of Internal Medicine; Lee RA, Centor RM et. al.

Apr 6th, 2021 - Antimicrobial overuse is a major health care issue that contributes to antibiotic resistance. Such overuse includes unnecessarily long durations of antibiotic therapy in patients with common bacterial infections, such as acute bronchitis with chro...

Treatment of Community-Acquired Pneumonia During the Coronavirus Disease 2019 (COVID-19...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236892
Annals of Internal Medicine; Metlay JP, Waterer GW

May 8th, 2020 - Treatment of Community-Acquired Pneumonia During the Coronavirus Disease 2019 (COVID-19) Pandemic.|2020|Metlay JP,Waterer GW,|epidemiology,therapy,epidemiology,therapy,epidemiology,epidemiology,microbiology,therapy,epidemiology,

ACR Appropriateness Criteria® Pneumonia in the Immunocompetent Child.
https://doi.org/10.1016/j.jacr.2020.01.033
Journal of the American College of Radiology : JACR; , Chan SS et. al.

May 7th, 2020 - Pneumonia is one of the most common acute infections and the single greatest infectious cause of death in children worldwide. In uncomplicated, community-acquired pneumonia in immunocompetent patients, the diagnosis is clinical and imaging has no ...

Diagnosis and Treatment of Adults With Community-Acquired Pneumonia.
https://doi.org/10.1001/jama.2019.21118
JAMA Olson G, Davis AM

Feb 7th, 2020 - Diagnosis and Treatment of Adults With Community-Acquired Pneumonia.|2020|Olson G,Davis AM,|drug therapy,adverse effects,therapeutic use,therapeutic use,drug therapy,drug effects,therapeutic use,

Diagnosis and Treatment of Adults with Community-acquired Pneumonia. An Official Clinic...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6812437
American Journal of Respiratory and Critical Care Medicine; Metlay JP, Waterer GW et. al.

Oct 2nd, 2019 - Background: This document provides evidence-based clinical practice guidelines on the management of adult patients with community-acquired pneumonia.Methods: A multidisciplinary panel conducted pragmatic systematic reviews of the relevant research...

see more →

Drugs  330 results see all →

Clinicaltrials.gov  74 results

A Retrospective, Real-world Study of ELP Used in the Expectorant Treatment of Community-acquired Pneumonia
https://clinicaltrials.gov/ct2/show/NCT05002192

Nov 25th, 2021 - Through a series of retrospective analysis, it is hoped that an objective evaluation of the effect and safety of Eucalyptol, Limonene and Pinene Enteric Soft Capsules in the treatment of community-acquired pneumonia can be made.

Oral Nemonoxacin in Treating Elderly Patients With CAP
https://clinicaltrials.gov/ct2/show/NCT05133752

Nov 24th, 2021 - This study was to evaluate the safety and efficacy of oral nemonoxacin in treating elderly patients (aged ≥ 65 years) with community-acquired pneumonia (CAP).

Real-World Efficacy and Safety Analysis of Omadacycline for the Treatment of Diabetic Foot Infections
https://clinicaltrials.gov/ct2/show/NCT04714411

Nov 17th, 2021 - This is a year-long study with planned enrollment of 57 patients (in addition to 114 historical control patients) evaluating the use of omadacycline for treatment of diabetic foot infections (DFI). Omadacycline (Nuzyra®) is a FDA approved antibiot...

Antibiotic Prescription in Children Hospitalized for Community-acquired Pneumonia
https://clinicaltrials.gov/ct2/show/NCT04681339

Nov 1st, 2021 - An observational study to document the antibiotic treatment rate of children hospitalized for community acquired pneumonia at a pediatric department with longstanding practice of restrictive antibiotic prescribing. Patients will be enrolled consec...

A Phase III Study to Evaluate the Efficacy and Safety of Intravenous Infusion of Nemonoxacin in Treating CAP
https://clinicaltrials.gov/ct2/show/NCT02205112

Oct 25th, 2021 - Community-acquired Pneumonia (CAP) remains a leading cause of death in both developing and developed countries. In the choice of antibacterial agents used to treat CAP, fluoroquinolones have received considerable attention because of their wide sp...

see more →

News  386 results

Pediatric Community Acquired Pneumonia: Lower Amoxicillin Dose and Shorter Duration May Be Effective
https://www.medscape.com/viewarticle/962250

Nov 4th, 2021 - Results of a gold-standard study published November 2 in JAMA hold promise for reducing the length of antibiotic courses for pediatric patients with pneumonia. Dr Julia Bielicki Julia Bielicki, PhD, of St George's University of London, London, Uni...

Support for Lower Dose and Shorter Course of Amoxicillin in Kids With Pneumonia
https://www.medscape.com/viewarticle/962065

Nov 3rd, 2021 - NEW YORK (Reuters Health) - For children with community-acquired pneumonia (CAP), a lower dose and shorter course of amoxicillin works just as well as a higher dose and longer course, according to results of the CAP-IT noninferiority trial. The be...

Two Factors Tied to Risk of Antibiotic Failure in Pneumonia Patients
https://www.medpagetoday.com/infectiousdisease/pneumonia/95087

Oct 15th, 2021 - Two factors, age and sex, were associated with a higher risk for antibiotic failure among clinically stable patients hospitalized with community-acquired pneumonia (CAP), a secondary analysis of a randomized trial suggested. Among nearly 300 CAP p...

Fast Five Quiz: Pneumococcal Infections
https://www.medscape.com/viewarticle/957889

Sep 15th, 2021 - Pneumococcal infections are caused by Streptococcus pneumoniae, a gram-positive, catalase-negative organism simply called pneumococcus. S pneumoniae is the most frequent cause of community-acquired pneumonia, bacterial meningitis, bacteremia, and ...

Fast Five Quiz: Pneumococcal Infections
https://reference.medscape.com/viewarticle/957889

Sep 15th, 2021 - Pneumococcal infections are caused by Streptococcus pneumoniae, a gram-positive, catalase-negative organism simply called pneumococcus. S pneumoniae is the most frequent cause of community-acquired pneumonia, bacterial meningitis, bacteremia, and ...

see more →

Patient Education  2 results see all →